Breaking News
Get Actionable Insights with InvestingPro+: Start 7 Day FREE Trial Register here
Investing Pro 0
Ad-Free Version. Upgrade your Investing.com experience. Save up to 40% More details
Close

Neuren Pharmaceuticals Ltd (NEU)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Add to/Remove from a Portfolio Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
3.610 +0.160    +4.64%
27/05 - Closed. Currency in AUD ( Disclaimer )
  • Volume: 192,108
  • Bid/Ask: 3.610 / 3.620
  • Day's Range: 3.510 - 3.720
Type:  Equity
Market:  Australia
ISIN:  NZNEUE0001S8 
Neuren Pharma 3.610 +0.160 +4.64%
BearishBullish
Start Date Username Call Open Rate End Date Chg. %
May 12, 2022 Giuseppe D'Erario   3.590 +0.56%
Apr 01, 2022 Giuseppe D'Erario   3.940 Apr 22, 2022 @ 3.900 -1.02%
Mar 23, 2022 Ron Steinwall   4.320 Apr 21, 2022 @ 3.930 -9.03%
Feb 06, 2022 Ermanno Rossini   3.800 Mar 05, 2022 @ 3.900 +2.63%
Dec 23, 2021 Ermanno Rossini   3.680 Jan 15, 2022 @ 3.530 -4.08%
Dec 16, 2021 domenico castellari   3.800 Dec 16, 2021 @ 3.800 0.00%
Dec 09, 2021 Bdr Zh   3.750 Dec 31, 2021 @ 3.770 +0.53%
Dec 08, 2021 Ron Steinwall   3.240 Dec 31, 2021 @ 3.770 +16.36%
Oct 21, 2021 Giuseppe D'Erario   1.800 Nov 12, 2021 @ 1.680 -6.67%
Oct 19, 2021 Ron Steinwall   1.850 Nov 12, 2021 @ 1.680 -9.19%
Aug 11, 2021 Giuseppe D'Erario   1.815 Sep 03, 2021 @ 2.420 +33.33%
Jun 30, 2021 Giuseppe D'Erario   1.630 Jul 23, 2021 @ 1.610 -1.23%
Mar 22, 2021 domenico castellari   1.350 Apr 17, 2021 @ 1.380 +2.22%
Mar 03, 2021 Tiziano Ghini   1.295 Mar 03, 2021 @ 1.295 0.00%
Feb 16, 2021 Tiziano Ghini   1.400 Feb 23, 2021 @ 1.315 -6.07%
Feb 11, 2021 Alpesh Patel   1.400 Mar 05, 2021 @ 1.250 -10.71%
Nov 22, 2020 domenico castellari   1.330 Nov 26, 2020 @ 1.290 -3.01%
Nov 16, 2020 domenico castellari   1.330 Nov 16, 2020 @ 1.330 0.00%
Oct 08, 2020 andrew dobb   1.130 Oct 30, 2020 @ 1.010 -10.62%
Sep 24, 2020 Alpesh Patel   1.160 Oct 16, 2020 @ 1.090 -6.03%
Jul 08, 2020 Giuseppe D'Erario   1.275 Jul 31, 2020 @ 1.290 +1.18%
May 07, 2020 Giuseppe D'Erario   1.685 May 29, 2020 @ 1.685 0.00%
Oct 14, 2019 Jason Bredin   2.360 Nov 08, 2019 @ 2.560 +8.47%
Oct 11, 2019 Ron Steinwall   2.440 Nov 01, 2019 @ 2.420 -0.82%
Sep 18, 2019 Pedro Opitz   2.160 Oct 11, 2019 @ 2.330 +7.87%
Aug 05, 2019 Giuseppe D'Erario   1.460 Aug 30, 2019 @ 1.900 +30.14%
Jul 11, 2019 Giuseppe D'Erario   1.375 Aug 02, 2019 @ 1.470 +6.91%
May 20, 2019 Pedro Opitz   1.180 Jun 14, 2019 @ 1.160 +1.69%
Apr 10, 2019 Giuseppe D'Erario   1.180 May 03, 2019 @ 1.180 0.00%
Jan 04, 2019 Giuseppe D'Erario   1.540 Feb 04, 2019 @ 0.055 -96.43%
Dec 18, 2018 QW Zhang   1.430 Jan 17, 2019 @ 0.055 +96.15%
Oct 19, 2018 Giuseppe D'Erario   1.275 Nov 18, 2018 @ 0.055 -95.69%
Sep 17, 2018 Giuseppe D'Erario   1.310 Oct 17, 2018 @ 0.055 -95.80%
Aug 28, 2018 Giuseppe D'Erario   1.050 Sep 17, 2018 @ 1.310 +24.76%
Jun 18, 2018 Pedro Opitz   2.760 Jul 18, 2018 @ 2.720 -1.45%
Apr 23, 2018 Pedro Opitz   3.020 May 23, 2018 @ 3.090 +2.32%
Feb 26, 2018 Pedro Opitz   3.250 Mar 28, 2018 @ 2.980 -8.31%
Aug 04, 2014 peter campbell   0.100 Sep 03, 2014 @ 0.100 -2.00%
Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

NEU Comments

Write your thoughts about Neuren Pharmaceuticals Ltd
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email